Logo
SearchSearch
Languages
Language
LoginSign up
Invest in Bioxcel Therapeutics Inc
Today
Create an eToro account to buy BTAI stock on a secure, user-friendly, multi-asset trading platform.
Buy Bioxcel Therapeutics Inc
BTAI Price
Bioxcel Therapeutics Inc BTAI
BTAI Price

Bioxcel Therapeutics Inc BTAI

$0.46-0.08(-15.49%)(1D)

BTAI Stock Price Chart

0.38%
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset positive trend

The Bioxcel Therapeutics Inc share price is rising this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The Bioxcel Therapeutics Inc share price today is 0.46, reflecting a -15.49% change over the last 24 hours and 25.36% over the past week. The current market capitalization of BTAI is 28.45M with an average volume in the last three months of 763919.05. The stock has a P/E ratio of -0.27 and a dividend yield of 0%. With the stock’s beta sitting at 1.41
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
$28.45M

Day’s Range
i
Shows the high and low prices of the day.
0.28 - 0.55

52W Range
i
Shows the high and low prices of the last year.
0.28 - 12.4

Average Volume (3M)
i
The average number of shares traded per day over the last three months.
763919.05

Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-0.27

Revenue
i
The total income generated by this company’s goods and services last year.
$2.28M

Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
0 (0%)

Prev Close
i
The final price of this asset at the end of the last trading day.
$0.57

EPS
i
A company’s total earnings divided by the number of shares it has issued.
-2.15

Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.41

What Is Bioxcel Therapeutics Inc?
BioXcel Therapeutics is a clinical-stage biopharmaceutical enterprise based in New Haven, Connecticut. It focuses on therapeutics in neuroscience and immuno-oncology. Established in 2017, the company operates locally in the US as a subsidiary of BioXcel. It trades under the BTAI ticker on the NASDAQ CM. Expand your investment portfolio with BTAI stock.

How can I buy Bioxcel Therapeutics Inc stocks?

To purchase Bioxcel Therapeutics Inc:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the Bioxcel Therapeutics Inc (BTAI) page and place an order to buy Bioxcel Therapeutics Inc.
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2024
Top Dividend Stocks for 2024
In times of market volatility, dividend investing provides investors with a steady source of income. eToro presents the top 6 dividend stocks to consider.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2024
AI Stocks Poised for Growth in 2024
Gear up for 2024 with a focus on AI stocks. Dive into the promising growth of C3.ai, Palantir Technologies, CrowdStrike, through eToro's expert analysis.
Read More
Graph
Buy Bioxcel Therapeutics Inc
Invest in Bioxcel Therapeutics Inc
Today
Create an eToro account to buy BTAI stock on a secure, user-friendly, multi-asset trading platform.

FAQ

The current price of BTAI is 0.46.
The average price target for Bioxcel Therapeutics Inc is 0.46. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for Bioxcel Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of Bioxcel Therapeutics Inc is 28.45M
Scroll to top